Ignite Creation Date:
2024-05-06 @ 7:43 PM
Last Modification Date:
2024-10-26 @ 3:12 PM
Study NCT ID:
NCT06110507
Status:
RECRUITING
Last Update Posted:
2023-10-31
First Post:
2023-10-25
Brief Title:
Chronic Anergic-anhedonic Depression Open Trial
Sponsor:
University Hospital Strasbourg France
Organization:
University Hospital Strasbourg France
Study Overview
Official Title:
Chronic Anergic-anhedonic Depression Open Trial
Status:
RECRUITING
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CADOT
Brief Summary:
A form of depression called dopamine-sensitive anergic-anhedonic syndrome is usually resistant to standard therapies TRAD On the other hand they respond to dopaminergic approaches for which recommendations have been developed DATA Dopaminergic Antidepressant Therapy Algorithm These are two stages starting with non-selective monoamineoxidase inhibitors MAOI or dopamine D2 receptor agonists D2RAG in monotherapy DATA1 and proposing to combine them in the event of a partial response DATA2
The effectiveness of this approach in the management of TRAD has not yet been evaluated in routine care
The aim of this study is to evaluate the feasibility and effectiveness in routine care of the DATA recommendations in the management of TRAD presenting to a specialized consultation for resistant depression short and long-term results
The effectiveness of this approach in the management of TRAD has not yet been evaluated in routine care
The aim of this study is to evaluate the feasibility and effectiveness in routine care of the DATA recommendations in the management of TRAD presenting to a specialized consultation for resistant depression short and long-term results
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None